Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Zoetis Inc.

ZTSNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$125.79
$-2.99(-2.32%)
U.S. Market opens in 15h 27m

Zoetis Inc. Fundamental Analysis

Zoetis Inc. (ZTS) shows strong financial fundamentals with a PE ratio of 20.51, profit margin of 28.23%, and ROE of 58.23%. The company generates $9.5B in annual revenue with moderate year-over-year growth of 8.33%.

Key Strengths

ROE58.23%
Operating Margin38.00%
Current Ratio3.03

Areas of Concern

Cash Position4.19%
PEG Ratio13.54
We analyze ZTS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 61.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
61.1/100

We analyze ZTS's fundamental strength across five key dimensions:

Efficiency Score

Excellent

ZTS demonstrates superior asset utilization.

ROA > 10%
17.28%

Valuation Score

Moderate

ZTS shows balanced valuation metrics.

PE < 25
20.51
PEG Ratio < 2
13.54

Growth Score

Moderate

ZTS shows steady but slowing expansion.

Revenue Growth > 5%
8.33%
EPS Growth > 10%
7.68%

Financial Health Score

Moderate

ZTS shows balanced financial health with some risks.

Debt/Equity < 1
2.85
Current Ratio > 1
3.03

Profitability Score

Excellent

ZTS achieves industry-leading margins.

ROE > 15%
58.23%
Net Margin ≥ 15%
28.23%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ZTS Expensive or Cheap?

P/E Ratio

ZTS trades at 20.51 times earnings. This indicates a fair valuation.

20.51

PEG Ratio

When adjusting for growth, ZTS's PEG of 13.54 indicates potential overvaluation.

13.54

Price to Book

The market values Zoetis Inc. at 16.46 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

16.46

EV/EBITDA

Enterprise value stands at 11.74 times EBITDA. This signals the market has high growth expectations.

11.74

How Well Does ZTS Make Money?

Net Profit Margin

For every $100 in sales, Zoetis Inc. keeps $28.23 as profit after all expenses.

28.23%

Operating Margin

Core operations generate 38.00 in profit for every $100 in revenue, before interest and taxes.

38.00%

ROE

Management delivers $58.23 in profit for every $100 of shareholder equity.

58.23%

ROA

Zoetis Inc. generates $17.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

17.28%

Following the Money - Real Cash Generation

Operating Cash Flow

Zoetis Inc. generates strong operating cash flow of $2.92B, reflecting robust business health.

$2.92B

Free Cash Flow

Zoetis Inc. generates strong free cash flow of $2.30B, providing ample flexibility for dividends, buybacks, or growth.

$2.30B

FCF Per Share

Each share generates $5.21 in free cash annually.

$5.21

FCF Yield

ZTS converts 4.12% of its market value into free cash.

4.12%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

20.51

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

13.54

vs 25 benchmark

P/B Ratio

Price to book value ratio

16.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.83

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.85

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.58

vs 25 benchmark

ROA

Return on assets percentage

0.17

vs 25 benchmark

ROCE

Return on capital employed

0.27

vs 25 benchmark

How ZTS Stacks Against Its Sector Peers

MetricZTS ValueSector AveragePerformance
P/E Ratio20.5129.28 Better (Cheaper)
ROE58.23%820.00% Weak
Net Margin28.23%-19743.00% (disorted) Strong
Debt/Equity2.850.26 Weak (High Leverage)
Current Ratio3.034.69 Strong Liquidity
ROA17.28%-17807.00% (disorted) Strong

ZTS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Zoetis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

55.65%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

74.46%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

73.18%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ